Philips' (PHG) second-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.
We recap the Q2 earnings report from Philips highlighted by comparable sales growth and a rebound in new orders. The company is settling litigation related to the global safety recall of its defective respiratory sleep apnea products. Improving financials and declining uncertainties support a positive outlook for the stock.
Koninklijke Philips N.V. (NYSE:PHG ) Q2 2024 Earnings Conference Call July 29, 2024 4:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Abhijit Bhattacharya - Chief Financial Officer Conference Call Participants Hassan Al-Wakeel - Barclays Richard Felton - Goldman Sachs David Adlington - JPMorgan Veronika Dubajova - Citi Hugo Solvet - Exane BNP Paribas Julien Ouaddour - Bank of America Robert Davies - Morgan Stanley Sezgi Ozener - HSBC Falko Friedrichs - Deutsche Bank Ed Ridley-Day - Redburn Operator Welcome to the Royal Philips Second Quarter and Semiannual 2024 Results Conference Call on Monday, July 29, 2024.
Philips Healthcare beat earnings this morning, reporting $0.52 per share in profit. Sales growth was slow, but Philips promised improvement later in the year.
American depositary receipts (ADRs) of Koninklijke Philips (PHG) jumped Monday after it reporting second-quarter earnings that saw comparable sales increase year-over-year as solid demand in the rest of the world offset a sales drop in China.
Shares of Philips jumped 8.5% in early deals Monday after the Dutch medical equipment marker reported expectation-beating second-quarter earnings.
Philips reported second-quarter results that beat analysts' expectations on Monday, boosted by higher earnings and the implementation of its restructuring program.
Philips (PHG) issues an urgent recall of SENSE XL Torso coils (1.5T and 3.0T) due to heating risks during MRI scans.
Advanced Manufacturing Minneapolis, now open for registration, will discuss and shape the future of the region's manufacturing landscape MINNEAPOLIS, MN / ACCESSWIRE / July 11, 2024 / Advanced Manufacturing Minneapolis , the Midwest's only annual end-to-end design and manufacturing event, today announces its keynote speakers set to discuss topics from artificial intelligence in medical devices to 3D technology in medicine, in the heart of the midwestern hub of medtech innovation, Minneapolis. Advanced Manufacturing Minneapolis, comprised of MD&M (Medical Design & Manufacturing Minneapolis), ATX (Automation Technology Expo), Design & Manufacturing, MinnPack, and Plastec events, returns October 16 &17 after a record-high 2023 event with over 5,300 attendees.
U.S. asset management firm Artisan Investments has raised its stake in Philips to 10%, sending the healthcare technology group's shares rising on Wednesday, a week after the Dutch company's biggest shareholder also increased its holding.
Philips (PHG) boosts Diagnosis & Treatment on the back of Precision Diagnosis and Image-Guided Therapy businesses and an expanding partner base.
Philips (PHG) boosts its Image-Guided Therapy portfolio with the Duo Venous Stent System, strengthening its Diagnosis & Treatment segment.